PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12649196-0	2003	Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.	Etoposide	62-71	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	40-45	
18820913-7	2009	RESULTS: Mitoxantrone, 5-Fu, adriamycin, Methotrexate, Pirarubicin, and Etoposide were identified as substrates of BCRP.	Etoposide	72-81	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	115-119	
12649196-0	2003	Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.	Etoposide	62-71	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	46-51	
12649196-1	2003	The breast cancer resistance protein [BCRP (BCRP/ABCG2)] has not previously been directly identified as a source of resistance to epipodophyllotoxins.However, when P-glycoprotein (P-gp)- and Mrp1-deficient mouse fibroblast and kidney cell lines were selected for resistance to etoposide, amplification and overexpression of Bcrp1 emerged as the dominant resistance mechanism in five of five cases.	Etoposide	277-286	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	38-42	
12649196-1	2003	The breast cancer resistance protein [BCRP (BCRP/ABCG2)] has not previously been directly identified as a source of resistance to epipodophyllotoxins.However, when P-glycoprotein (P-gp)- and Mrp1-deficient mouse fibroblast and kidney cell lines were selected for resistance to etoposide, amplification and overexpression of Bcrp1 emerged as the dominant resistance mechanism in five of five cases.	Etoposide	277-286	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	44-48	
12649196-1	2003	The breast cancer resistance protein [BCRP (BCRP/ABCG2)] has not previously been directly identified as a source of resistance to epipodophyllotoxins.However, when P-glycoprotein (P-gp)- and Mrp1-deficient mouse fibroblast and kidney cell lines were selected for resistance to etoposide, amplification and overexpression of Bcrp1 emerged as the dominant resistance mechanism in five of five cases.	Etoposide	277-286	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	49-54	
12649196-4	2003	Transduced wild-type Bcrp1 cDNA mediated resistance to etoposide and teniposide in fibroblast lines and trans-epithelial etoposide transport in polarized Madin-Darby canine kidney II cells.	Etoposide	55-64	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	21-26	
12649196-4	2003	Transduced wild-type Bcrp1 cDNA mediated resistance to etoposide and teniposide in fibroblast lines and trans-epithelial etoposide transport in polarized Madin-Darby canine kidney II cells.	Etoposide	121-130	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	21-26	
12649196-5	2003	Bcrp1-mediated etoposide resistance was reversed by two structurally different BCRP/Bcrp1 inhibitors, GF120918 and Ko143.	Etoposide	15-24	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	0-5	
12649196-5	2003	Bcrp1-mediated etoposide resistance was reversed by two structurally different BCRP/Bcrp1 inhibitors, GF120918 and Ko143.	Etoposide	15-24	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	79-83	
12649196-5	2003	Bcrp1-mediated etoposide resistance was reversed by two structurally different BCRP/Bcrp1 inhibitors, GF120918 and Ko143.	Etoposide	15-24	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	84-89